These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26608326)

  • 1. An approach to death as an adverse event following immunization.
    Gold MS; Balakrishnan MR; Amarasinghe A; MacDonald NE
    Vaccine; 2016 Jan; 34(2):212-217. PubMed ID: 26608326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use.
    Tozzi AE; Asturias EJ; Balakrishnan MR; Halsey NA; Law B; Zuber PL
    Vaccine; 2013 Oct; 31(44):5041-6. PubMed ID: 24021304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience.
    Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML
    Expert Rev Vaccines; 2018 Jun; 17(6):555-562. PubMed ID: 29865876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the revised WHO causality assessment protocol for adverse events following immunization in India.
    Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML
    Vaccine; 2017 Jul; 35(33):4197-4202. PubMed ID: 28648545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.
    Gao D; Dong G; Zhu L; Jia N; Sun B
    Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.
    De Alwis KN; Abeysinghe MR; Wickramesinghe AR; Wijesinghe PR
    Vaccine; 2014 Feb; 32(8):924-30. PubMed ID: 24406391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causality assessment of adverse events following immunization: the problem of multifactorial pathology.
    Bellavite P
    F1000Res; 2020; 9():170. PubMed ID: 32269767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening of causality assessment of adverse events following immunization in the WHO South East Asia and Western Pacific regions: Lessons from the 2014 SEAR inter-country workshop.
    MacDonald NE; Guichard S; Amarasinghe A; Balakrishnan MR;
    Vaccine; 2015 Nov; 33(48):6902-7. PubMed ID: 25617790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on the characteristics of suspected vaccine-related deaths in Fujian Province, 2012-2017].
    Xiao JX; Lin ZQ; Wu RH; Zhou Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):719-723. PubMed ID: 31288344
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic causality assessment of adverse events following HPV vaccines: Analysis of current data from Apulia region (Italy).
    Tafuri S; Fortunato F; Gallone MS; Stefanizzi P; Calabrese G; Boccalini S; Martinelli D; Prato R
    Vaccine; 2018 Feb; 36(8):1072-1077. PubMed ID: 29358055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons on causality assessment and communications from the 2019 South-East Asia Regional (SEAR) workshop on inter-country expert review of selected Adverse Events Following Immunization (AEFI) cases.
    MacDonald NE; Guichard S; Arora N; Menning L; Wilhelm E;
    Vaccine; 2020 Jul; 38(32):4924-4932. PubMed ID: 31611095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events following immunization: is this time for the use of WHO causality assessment?
    Tafuri S; Gallone MS; Calabrese G; Germinario C
    Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following HPV vaccination, Alberta 2006-2014.
    Liu XC; Bell CA; Simmonds KA; Svenson LW; Russell ML
    Vaccine; 2016 Apr; 34(15):1800-5. PubMed ID: 26921782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis on death from adverse event following immunization surveillance system of Shandong Province during 2011-2016].
    Zhang YJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):723-727. PubMed ID: 28763922
    [No Abstract]   [Full Text] [Related]  

  • 17. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
    Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.
    Cheng DR; Perrett KP; Choo S; Danchin M; Buttery JP; Crawford NW
    Vaccine; 2015 Mar; 33(13):1602-7. PubMed ID: 25698493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Loughlin AM; Marchant CD; Adams W; Barnett E; Baxter R; Black S; Casey C; Dekker C; Edwards KM; Klein J; Klein NP; LaRussa P; Sparks R; Jakob K
    Vaccine; 2012 Nov; 30(50):7253-9. PubMed ID: 23063829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.